Filing Details
- Accession Number:
- 0001140361-11-022415
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-18 15:45:34
- Reporting Period:
- 2011-03-04
- Filing Date:
- 2011-04-18
- Accepted Time:
- 2011-04-18 15:45:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1296391 | Tengion Inc | TNGN | Biological Products, (No Disgnostic Substances) (2836) | 200214813 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1341125 | Richard Kuntz | C/O Tengion, Inc. 2900 Potshop Lane, Suite 100 East Norriton PA 19403 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock ($0.001 Par Value) | Acquisiton | 2011-03-04 | 2,473,500 | $2.83 | 2,473,500 | No | 4 | P | Indirect | (1) |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | (1) |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock ($0.001 Par Value) | Common Stock Warrant (right to buy) | Acquisiton | 2011-03-04 | 1,855,125 | $0.00 | 1,855,125 | $2.88 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,855,125 | No | 4 | P | Indirect |
Footnotes
- Dr. Kuntz is employed by Medtronic, Inc. as Senior Vice President and Chief Scientific, Clinical and Regulatory Officer. Pursuant to the Securities Purchase Agreement dated March 1, 2011, Medtronic, Inc. acquired 2,473,500 shares of common stock and warrants to purchase 1,855,125 shares of common stock. Dr. Kuntz disclaims beneficial ownership of the common stock and warrants held by Medtronic, Inc.
- Subject to any restrictions set forth in the Warrant Agreement, all or any part of the warrant may be exercisable by Medtronic, Inc. at any time and from time to time on or after the original issue date of March 4, 2011 and through and including 5:30 P.M., New York City time, on March 4, 2016. At 5:30 P.M., New York City time, on March 4, 2016, the portion of the warrant not exercised prior thereto shall be and become void and of no value and the warrant shall be terminated and no longer outstanding.